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In virtually all studies with MA-10 cells, progesterone RIAs
have been used to measure steroid synthesis. To test whether
progesterone is a stable end product, we investigated the me-
tabolism of added tritiated progesterone and pregnenolone in
MA-10 cells over a period of 3 h. Steroids were then extracted,
separated by HPLC, and identified by GC/MS. We found that
more than 70% of radiolabeled steroids were converted to at
least five different metabolites. A major metabolite (40%) was
5-pregnan-3 or 3-ol-20one. Similar studies, using radiola-
beled T, demonstrated conversion to dihydrotestosterone and
two forms of 5-androstane-diols. These data indicate the
presence of active 5-reductase and 3- and/or 3-hydroxy-
steroid dehydrogenase activities in MA-10 cells.
Because these results suggest that progesterone is an
unstable end product, to gauge the level of active metabo-
lism, we incubated cells in the presence of inhibitors of
pregnenolone metabolism and assessed pregnenolone lev-
els by RIA. We discovered that basal levels of steroidogen-
esis in MA-10 cells were considerably higher than previ-
ously estimated. Moreover, dibutyryl cAMP-stimulated
steroid production was linear over more than 13 h, in con-
trast to previous findings that measured progesterone lev-
els. Other consequences of inaccurate assessment of steroi-
dogenic activity in MA-10 cells because of the application of
the progesterone assay are discussed. (Endocrinology 142:
5236–5242, 2001)
THE MOUSE LEYDIG tumor cell line MA-10 is widelyused as a model system for investigations on the reg-
ulation of steroidogenesis. The cells can be grown in culture
and possess functional LH/human CG (LH/hCG) receptors
that mediate a very strong stimulation of progesterone pro-
duction (1). The cells show all the features of normal Leydig
cells, except that the amount of P450c17 mRNA and P450c17
activity is insignificant (2). Consequently, the production of
androgens by these Leydig cells is almost undetectable; and
instead, large quantities of progesterone are produced (1, 2).
Because only small amounts of 20-dihydroprogesterone are
produced and few other metabolites have been identified
during short-term incubations, changes in the levels of pro-
gesterone, as determined by RIA, have been used as a stan-
dard measure for the overall steroidogenic activities of
MA-10 cells. This procedure has been used by nearly all
investigators over a period of 15 yr. However, it has been
reported that accumulated progesterone in medium of stim-
ulated MA-10 cells is decreased to almost basal levels after
24 h of incubation (3). This clearly indicates active metabo-
lism of progesterone. Although the linear increase in pro-
gesterone levels in the incubation medium, by stimulated
MA-10 cells, during the first hours suggests that progester-
one is not metabolized at this time, progesterone levels do not
further increase after 6–8 h (1, 4–6). This has been widely
interpreted to mean that with long-term stimulation, there is
an exhaustion of steroid-synthesizing capabilities or a de-
sensitization to trophic stimulus in MA-10 cells, resulting in
a decline in steroidogenesis. However, levels of 20-dihy-
droprogesterone increase linearly over at least 12 h (1). More-
over, normal Leydig cells isolated from mouse testes do not
show such a tendency for decreased steroid production, not
even after 24 h of stimulation (7, 8). The diminished accu-
mulation of progesterone after 6–8 h could also result from
an increased influence of progesterone metabolism. Al-
though only a limited variety of progesterone byproducts
have been identified, major metabolites may have escaped
detection because of limited separation power of the previ-
ously used chromatography systems (1, 5). If the level of
progesterone metabolism is indeed significantly underesti-
mated, progesterone assays will not give an accurate mea-
sure of total steroidogenesis in MA-10 cells. In fact, they
could provide misleading data.
We (see Refs. 10 and 11) have previously established con-
ditions to measure total steroidogenesis in immature rat Ley-
dig cells, which are very active in the metabolism of T (9).
This was possible by completely inhibiting the metabolism of
pregnenolone without affecting its biosynthesis (10, 11). In
the presence of these inhibitors, the only steroidogenic prod-
uct made by these rat Leydig cells is pregnenolone. By mea-
suring this immediate end product of cholesterol side-chain
cleavage activity, we were able to measure the true rate of
steroidogenesis in rat Leydig cells without complications of
steroid metabolism. In a study on LH receptor activation by
different hCG preparations and using MA-10 cells, we found
that the measured biological activity of the various hCG
preparations depended on the type of RIA (for progesterone
or for pregnenolone) used for measuring steroid production
(12). We suggested that the discrepancies between the results
of the two assays could result from progesterone metabolism.
For this reason, we have reinvestigated the steroid metabolic
Abbreviations: AMG, Aminoglutethimide; dbcAMP, dibutyryl
cAMP; hCG, human CG.
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enzyme activities in MA-10 cells. We have also evaluated
whether the pregnenolone method, previously used for rat
Leydig cells, can be applied to MA-10 cells and also how this
method compares with the progesterone assay.
Materials and Methods
RPMI-1640, horse serum, and FCS were from Grand Island Biochem-
ical Co. (Grand Island, NY). BSA was from Sigma (St. Louis, MO).
Diethylether, n-hexane, and 2-propanol (all LiChrosolv) were purchased
from Merck & Co., Inc. (Darmstadt, Germany). Highly purified hCG was
kindly provided by Organon International (Oss, The Netherlands). SU-
10603 [7-chloro-3,4-dihydro-2-(3-pyridyl)-1-(2H)-naphthalenone] was a
gift from Ciba-Geigy (Basel, Switzerland). Epostane or WIN-32729
(4,5-epoxy-17-hydroxy-4,17-dimethyl-3-oxo-androstane-2-
carbonitrile) was a gift from Sterling-Winthrop (New York, NY). Fin-
asteride [17-(N-tert-butylcarbamoyl)-4-aza-5-androstan-1-en-3-one]
was a gift from Merck & Co., Inc. (Rahway, NJ). [7-3H]-Pregnenolone,
[1,2,6,7-3H]-progesterone (3.37 TBq/mmol), [1,2,6,7-3H]-T (3.63 TBq/
mmol) were purchased from Amersham Pharmacia Biotech (Bucking-
hamshire, UK).
MA-10 cells (1) were generously donated by Dr. Mario Ascoli (Uni-
versity of Iowa, Iowa City, IA). Cells were grown under standard con-
ditions in RPMI-1640 medium supplemented with 10% horse serum, 100
g/ml streptomycin sulfate, 100 IU/ml penicillin, and 2 mm l-gluta-
mate, at 37 C, under humidified atmosphere containing 95% air-5% CO2.
The cells were subcultured after trypsin treatment (0.05% wt/vol tryp-
sin), and experimental cultures were plated and cultured for 2 d. After
washing twice with RPMI-1640 containing 0.1% BSA, approximately 106
cells were used per experiment.
Steroids were measured in the incubation medium and/or in the cells
after incubation at 37 C for various periods in RPMI-1640 medium or in
Krebs Ringer buffer solutions, containing either 0.1% BSA or 1% FCS.
Depending on the type of experiments, epostane (5 m) was added from
stock solution to inhibit 3-hydroxysteroid dehydrogenase activity. In
some experiments, 20 m SU-10603 was also added to inhibit residual
activities of 17-hydroxylase/desmolase. Steroids in culture medium
(300 l) or sonified cells (see below) were measured with RIAs previ-
ously described for pregnenolone (10, 11), 20-dihydroprogesterone
(13), and progesterone (14). The steroid specificities of the three antisera
used are given in Table 1. For measurement of cellular steroid levels, cells
were washed with RPMI-1640 medium and were trypsin treated (0.05%
wt/vol). After sonification, 300 l of the resulting homogenate was used
for measurement of steroid levels. For investigation of progesterone,
pregnenolone, or T metabolism, 0.03–30 nmol 3H-labeled steroids were
added to the culture medium. After incubation for 3 h, culture medium
was extracted three times with ethyl acetate, and the metabolites were
separated by HPLC with online radiodetection as described previously
(15). In short, metabolized steroids were separated on a Hibar LiChro-
sorb Diol-column (length, 250 mm; diameter, 5 m; Merck & Co., Inc.,
Rahway, NJ), equipped with a guard column (Resolve Silica, Waters
Corp., Milford, MA). The HPLC-system included a Waters 610 Fluid
Unit, a Waters 600E System Controller and a Waters U6K injector. The
isocratic flow of the mobile phase (hexane/propanol 96:4, vol/vol) was
1.5 ml/min. Radioactivity was monitored with a FloOne  Radiomatic
A500 radiochromatography detector (Packard-Canberra Benelux,
Tilburg, The Netherlands) with a 500-l cell and a liquid scintillation
flow of 1.5 ml/min (Aqua-Luma, Lumac-LSC, Olen, Belgium).
For identification of an unknown major metabolite, various batches
of MA-10 cells were incubated for 3 h, with 30 nmol pregnenolone per
106 MA-10 cells, until approximately 10 g pregnenolone-like steroids
could be measured in the combined ethylacetate extracts. During the
HPLC separation procedure, the major metabolite was collected. After
trimethylsilyl-enol-trimethylsilyl derivatization, steroid fractions were
directly used for gas chromatographic/mass spectrometric (GC/MS)
analysis. GC/MS analysis was performed on a 5790 Gas Chromatograph
(Hewlett-Packard Co., Palo Alto, CA) coupled to a 5970 Mass Selective
Detector (MSD, Hewlett-Packard Co.). Structural information about the
major metabolite was obtained by comparing the mass spectrum of the
metabolite with those of authentic reference steroids. Further details
about this procedure can be found in Ref. 16.
Data are expressed as means  sd and analyzed for statistical sig-
nificance using the t test. Values of P less than 0.01 were considered
significant.
Results
Steroidogenesis, under basal conditions and during stim-
ulation with hCG, was measured by incubating MA-10 cells,
without or with epostane and SU-10603, to determine to what
extent pregnenolone metabolism is inhibited. The secreted
steroids in the culture media were measured with three dif-
ferent RIAs, and the results are presented in Table 2. Results
from the progesterone assay confirm what has been observed
previously for MA-10 cells: control cells secrete very small
amounts of progesterone, and the production is increased
approximately 200-fold after hCG stimulation. When MA-10
cells were incubated in the presence of epostane and SU-
10603, which completely inhibit 3-hydroxysteroid dehy-
drogenase and 17-hydroxylase/desmolase activity in rat
Leydig cells, progesterone synthesis was reduced by nearly
85%. The data further confirm that MA-10 cells also, in ad-
dition to progesterone, produce 20-dihydroprogesterone.
The generation of this steroid was similarly stimulated by
hCG and affected by the presence of these inhibitors of preg-
nenolone metabolism. When MA-10 Leydig cells were incu-
bated with these inhibitors and the RIA for pregnenolone
was applied, higher amounts of steroids were measured than
with the progesterone assay. Surprisingly, when epostane
and SU-10603 were omitted, there was only a marginal effect
on the outcome of the pregnenolone assay. This is particu-
larly remarkable because the inhibitors were active, as could
be concluded from the concomitant attenuation of proges-
terone production. This apparent discrepancy can be under-
stood if pregnenolone-like metabolites are formed that in-
teract with the antipregnenolone antibody (Table 1).
TABLE 1. Steroid specificity of three RIAs
Cross-reacting steroid
Antibody against steroid-BSA conjugate (BSA conjugation position on steroid)
Pregenolone (3) Progesterone (11) 20-OH Progesterone (11)
5-pregnen-3-ol-20one 100 1 ND
5-pregnen-3, 17-diol-20one 8 ND 1
4-pregnen-3,20dione 20 100 1
4-pregnen-20-ol-3one 5 1 100
4-pregnen-3,17-diol-20one 8 2 1
4-pregnen-3,11-diol-20one 1 30 1
4-pregnen-11,17,21-triol-3,20dione 29 1 1
5-pregnan-3,20dione 20 11 1
5-pregnan-3/-ol-20one 50 ND ND
4-androsten-17-ol-3one 1 1 1
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The metabolism of radioactively labeled pregnenolone
and progesterone was therefore investigated under condi-
tions that are frequently employed in studies with MA-10
cells. When cells were incubated for 3 h with low amounts
of progesterone that are similar to basal levels (0.03 nmol),
more than 95% of the steroid was metabolized (Fig. 1). When
1000-fold more progesterone was added, a level similar to
that present when cells are maximally stimulated, approxi-
mately 70%, was metabolized during 3 h of incubation. These
data show that added progesterone is extensively metabo-
lized by MA-10 cells and a major metabolite that is formed
is compound A. Moreover, the extent of this metabolism and
the pattern of the metabolites depends on the concentration
of progesterone or pregnenolone used (Fig. 1 and Table 3).
When cells are incubated with pregnenolone, a major part of
this precursor is also converted to compound A, and only a
minor fraction to progesterone. In the presence of epostane
and SU-10603, there was a higher yield of pregnenolone, but
the major steroid present was still compound A, not preg-
nenolone. Higher concentrations of these drugs failed to
further inhibit pregnenolone metabolism (data not shown).
To discover the identity of compound A, this steroid prod-
uct was collected by an HPLC separation procedure. Mass-
spectrometry analysis determined this compound to be
either 5-pregnan-3-ol-20one or 5-pregnan-3-ol-20one,
indicating that 3 and/or 3-hydroxysteroid dehydrogenase
and 5-steroid reductase enzyme activities are very active in
MA-10 cells. These enzyme activities, together with the
known 5-4 isomerase and 20-hydroxysteroid dehydro-
genase activities, can give rise to many different products.
We have not attempted to characterize the remaining me-
tabolites; but, to measure the 3 and/or 3-hydroxysteroid
dehydrogenase and 5-steroid reductase enzyme activities
without interference of 5-4 isomerase and 20-hydroxy-
steroid dehydrogenase activities, steroid metabolism was
also investigated using T as a substrate. The results in Fig. 2
and Table 4 show that T was metabolized to dihydrotestos-
terone, 5-androstane-3,17-diol, and probably 5-andro-
FIG. 1. Metabolism of 0.03 nmol 3H-labeled progesterone (left), 30 nmol 3H-labeled progesterone (middle), or 0.03 nmol 3H-labeled pregnenolone
by 106 MA-10 cells in 3 h. Metabolism of pregnenolone occurred in the presence of 5 m epostane (EP) and 20 m SU-10603 (SU). Steroids
were extracted from the culture media and separated by HPLC. The black peak indicates the substrate that remained after the incubation. The
distribution of radioactivity over the four mean peaks A, B, C, and D is given in Table 3. In this table, results from other studies on pregnenolone
metabolism are also shown.
TABLE 3. Distribution of radioactivity over metabolites, as indicated in Fig. 1a
Substrate nmol (inhibitors) % Prog % Polon % A % B % C % D % Others
Prog 0.03 7 37 4 35 4 13
Prog 30 31 31 14 1 6 17
Polon 0.03 (SUEP) 2 30 56 1 10 1
Polon 0.03 (SUEPFi) 7 41 38 6 3 5
Polon 0.03 2 6 39 2 50 1
Polon 30 18 10 40 18 11 3
a Metabolism was studied with different amounts of substrate and inhibitors. For further information, see Fig. 1 legend. Fi, 5 M finasteride;
Prog, progesterone; Polon, pregnenolone.
TABLE 2. Steroids (pmol) measured in incubation medium after incubation of 4  105 MA-10 cells for 3 h without or with 0.1 nM hCG
Condition RIA
Without inhibitors With inhibitors EP and SU
Progesterone 20-Progesterone Pregnenolone Progesterone 20-Progesterone Pregnenolone
Control (a) 2.6  0.1 0.8  0.1 7.9  0.2 2.7  0.1 0.6  0.1 15.6  0.4
hCG (b) 510  43a 54  2a 620  75a 80  3a 6.4  0.3a 680  52a
Approx. ratio b/a 200 70 80 30 10 40
Results from three different RIAs are shown. Steroids were measured in plain incubation medium and in medium containing a mixture of
5M epostane (EP) and 20M SU-10603 (SU), which inhibit, in rat Leydig cells, 3-hydroxysteroid dehydrogenase activity and 17-hydroxylase/
desmolase activity, respectively. The steroid specificities of the three different antibodies are shown in Table 1. Mean results  SD of four to
eight observations are shown.
a Significantly different from controls (P  0.01).
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stane-3,17-diol. From these results it can again be inferred
that both 3/-hydroxysteroid dehydrogenase and 5-
steroid reductase enzyme activities are active in MA-10 cells.
Similar to when progesterone or pregnenolone was used as
a substrate, the percent conversion of T decreased when
higher concentrations of substrate were used.
Because 5-steroid reductase is a major activity and 5-
reduced steroids could be preferential substrates for 3- or
3-hydroxysteroid dehydrogenases, we also attempted to
inhibit conversion of radiolabeled pregnenolone through this
metabolic pathway, by inclusion of finasteride in the mixture
of inhibitors. At a concentration of 5m, 5-steroid reductase
activity in MA-10 cells was indeed inhibited (Table 3). Al-
though, under these conditions, more pregnenolone was re-
covered and less metabolites were formed, the inhibition of
pregnenolone conversion was still incomplete. We have not
used this compound as an additional inhibitor for measuring
endogenous steroid production, because 3m finasteride can
reduce cytochrome P450scc enzyme activity by more than
50% in MA-10 cells (17).
Because the 5-pregnan-3/-ol-20one isomers, proges-
terone (4-pregnen-3,20-dione), and 5-pregnan-3,20-dione
have 50%, 20%, and 20% cross-reactions, respectively, with
the antipregnenolone antibody, the levels of these steroids
are also partly measured with the pregnenolone RIA. Using
this nonspecific assay, the total endogenous production of
progesterone, pregnenolone, 5-pregnan-3/-ol-20one and
possibly other pregnenolone-like steroids seemed to be lin-
ear up to 13 h (Table 5). A substantial fraction of this steroid
mixture was cellular-bound; and therefore, this fraction can-
not be ignored when assessing total steroid synthesis. The
results also showed that, in the presence of the cholesterol
side-chain cleavage enzyme inhibitor aminoglutethimide
(AMG) (18), endogenous steroid production is inhibited by
more than 99%. Thus, the nonspecific pregnenolone assay
does not measure nonsteroidal compounds in the culture
medium. When MA-10 cells were preincubated in the pres-
ence of AMG and dbcAMP for 13 h, upon removal of AMG,
the rate of steroidogenesis was 2-fold higher than in MA-10
cells treated for only 2 or 4 h with dbcAMP alone (Table 5,
ratio d/a or d/b). This indicates that the rate of steroid
production after long-term stimulation of MA-10 cells does
not decrease but shows a clear tendency to increase.
Discussion
The present data show that added progesterone can be
metabolized by MA-10 cells to such an extent that it can be
present as a minor steroid, when compared with its metab-
olites. This metabolism was measured after the addition of
labeled progesterone, as a large bolus, to the culture medium.
It is possible that endogenous steroid precursors that are
continuously produced in low amounts, close to steroid-
converting enzymes in the endoplasmic reticulum, may be
preferentially metabolized, because these enzymes show a
preference for particular substrates (19, 20).
If this occurs in our experiments, the pattern of steroid
metabolites from added labeled pregnenolone or progester-
FIG. 2. Metabolism of 0.3 nmol 3H-labeled T by 106 MA-10 cells in 3 h.
Two peaks could be identified with standards: 1 is dihydrotestoster-
one (DHT) and 2 is 5-androstane-3,17-diol (3 Adiol). Peak X was
not identified but is probably 5-androstane-3,17-diol. The distri-
bution of radioactivity over the four fractions is given in Table 4.
TABLE 4. Distribution of radioactivity over four fractions, as
indicated in Fig. 2
Substrate (nmol) % Test % DHT % Adiol % X
Test (0.03) 37 17 38 7
Test (0.3) 45 17 30 8
Test (30) 75 7 11 7






(5 M) Medium Cells Total Ratio
13   0.03 0.04 0.07
0.07 0.04 0.1
2   (a) 1.1 0.9 1.9
0.9 1.1 2.0
4   (b) 2.9 2.0 5.0 b/a 2
2.3 2.0 4.3
13   (c) 7.4 6.5 14 c/a 7
6.7 7.0 14
13   0.03 0.08 1.1
with 500 M AMG 0.03 0.06 1.0
2   (d) 1.9 1.4 3.4 d/a 2
after 13 h preincubation with 500 M AMG and
subsequent removal of the AMG
1.9 2.4 4.3
13   (e) 3.3 0.3 3.6
3.1 0.4 3.5
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one may be slightly different from the endogenously pro-
duced steroids. Still, the observed metabolism of added pro-
gesterone, pregnenolone, or T clearly shows that there are
active steroid metabolizing enzymes present in MA-10 cells.
Irrespective of the exact profile of the metabolites, active
metabolism of progesterone will lead to an underestimation
of the true steroidogenic activities of the MA-10 cells. A
similar problem was previously encountered when the ste-
roidogenic activity of immature rat Leydig cells (9) or rat
H540 tumor cells (21) was measured with an RIA for T.
Unlike mature Leydig cells, immature rat Leydig cells and rat
H540 tumor cells are very active in metabolizing T; and
hence, the measurement of T as an end product of steroid
synthesis grossly underestimates the steroidogenic activity
of these cells. Accurate analysis of steroidogenesis in these rat
Leydig cells, however, is possible because metabolism of
pregnenolone can be abolished after inhibitors are added and
pregnenolone accumulation is assessed by RIA (10, 11).
These inhibitors also reduced pregnenolone conversion in
MA-10 cells, but the inhibition was incomplete. However,
because the major metabolites, 5-pregnan-3/-ol-20one
and progesterone, also partly cross-react with the antipreg-
nenolone antibody, this nonspecific RIA gives a better,
though not perfect, impression of the total steroidogenic
activity than can be derived from specific progesterone mea-
surements. Similar findings were reported by Purvis et al. (9)
in 1978, when they were able to show hCG responsiveness
of immature Leydig cells with a nonspecific 17-
hydroxyandrogen assay but not with a specific T assay. Un-
fortunately, our attempts to improve the reliability of the
pregnenolone assay for MA-10 cells by adding finasteride to
further inhibit pregnenolone metabolism were unsuccessful.
Although the pregnenolone assay is imperfect, it gives a
much better impression about steroid production than can be
derived from progesterone assays. The discrepancies be-
tween the two assays seemed most pronounced when low
amounts of steroid were produced, as from unstimulated
MA-10 Leydig cells, or when high amounts of steroids were
produced, when cells are chronically stimulated. Some ex-
amples and consequences of inaccurate assessment of ste-
roidogenic activities in MA-10 cells in the literature are dis-
cussed below.
Our observations with the pregnenolone assay of unstimu-
lated MA-10 cells show that these cells produce more steroids
than previously thought. The reported very low progester-
one production by unstimulated MA-10 cells (1, 4, 5) thus
seems to be more a reflection of a high metabolic rate than
of a very low rate of steroidogenesis. If small amounts of
progesterone are almost completely metabolized, this could
also explain why progesterone synthesis in MA-10 cells re-
sponds relatively slowly to hCG stimulation, when com-
pared with T production in normal mouse (22) or rat (23)
Leydig cells.
Because unstimulated MA-10 cells are more active in ste-
roidogenesis than heretofore recognized, this also affects the
observed stimulation factor of steroid synthesis induced by
the addition of trophic hormones. The stimulation factor in
MA-10 cells, using the pregnenolone RIA, was approxi-
mately 30. This is very close to the data published for rat
Leydig cells but much lower than the more-than-200-fold or
higher acute stimulation factors derived from progesterone
measurements in MA-10 cells (4, 6, 24). Thus, progesterone
assays may give a false impression of the kinetics of steroid
production and its responsiveness to hormonal stimulation.
Our observations with the pregnenolone assay showed
that stimulated MA-10 cells continue to produce steroids
over a period of at least 13 h. This corroborates an earlier
observation that the production of 20-dihydroprogester-
one, but not progesterone, is constant for at least 12 h (1). It
also seems, from our data, that the rate of steroid production
does not decrease over this time but may instead increase,
given that steroidogenesis after 13 h is higher than the rate
of steroid production during the first 4 h. This is in line with
the reported increase in cholesterol side-chain cleavage en-
zyme activity after 24 h incubation with dbcAMP (24).
Thus, the plateau of progesterone levels in culture medium
after incubation of MA-10 cells for 6–8 h (1, 4) most likely
results from a high rate of progesterone metabolism and does
not originate from a decline in steroid synthesis. This influ-
ence of metabolism is often ignored, and changes in proges-
terone levels are often interpreted to be a direct consequence
of changes in steroidogenesis. For instance, changes in pro-
gesterone have been presented, in a relative fashion, as a
percentage of maximal expression, with the maximal level of
progesterone taken as 100%, and these relative steroid values
have been compared with StAR mRNA levels (4). Because
progesterone and StAR mRNA levels develop in a similar
fashion and both reach a plateau after approximately 6 h, it
was concluded that the rate of StAR mRNA synthesis par-
allels that of steroid production. However, when progester-
one metabolism is taken into account, the plateau probably
more accurately reflects a balance between metabolism and
production, not a slowdown in steroid synthesis. In addition,
using the pregnenolone assay, the present data show that the
true steroidogenic activity and StAR mRNA levels do not
correlate after 6 h. Presumably, the early accumulation and
later decline in StAR mRNA levels should yield changes in
the levels of StAR protein and, thus, changes in the rate of
steroid production. However, our data from the preg-
nenolone assay, as well as the data from the progesterone
assays up to 6 h, revealed a linear increase in steroid levels
and thus a constant rate of steroidogenesis. Therefore, the
significance of changes in StAR mRNA levels for steroido-
genic activity remains unclear at this time.
Discrepancies between the apparent and the real steroi-
dogenic activity are very clear after prolonged incubation
periods, because progesterone levels in media from stimu-
lated cells not only reach a plateau but also diminish after 6 h
of stimulation (3). Because of this metabolism of progester-
one, the apparent level of steroidogenesis in MA-10 cells
induced by LH was found to be 10-fold less when an incu-
bation period of 24 h was used instead of 4 h (3).
Because of the observed discrepancies between real and
apparent steroidogenic activities, not only during prolonged
incubation periods of stimulated cells but also during short-
term incubations of unstimulated cells, it remains to be
determined whether reliable information can be obtained
concerning the fine regulation of steroidogenesis from pro-
gesterone measurements. By using normal mouse Leydig
cells and measuring T levels, important information on the
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regulation of steroid production was obtained from careful
kinetic studies over 4- to 5-h periods (22). It was shown that
very low concentrations of hCG that do not give detectable
changes in cAMP and PKA activation can almost maximally
stimulate T production, but the increase in this steroidogenic
activity is only detectable after a delay of 3–4 h (22). The
authors concluded from their kinetic experiments that sub-
maximal stimulation of steroidogenesis is more the result of
a delayed onset than of a reduced rate. The slow increase in
the rate of T production, against a background of basal ste-
roid production, could only be measured because T was not
metabolized. Because progesterone is not a stable end prod-
uct, this important conclusion about dose-dependent regu-
lation of steroid production cannot be validated for MA-10
cells. It seems necessary to do this because it has been sug-
gested that considerably higher cAMP concentrations are
required for acute stimulation of steroidogenesis than for
synthesis of P450scc in MA-10 cells (24). This conclusion was
made after incubating MA-10 cells, for 24 h, with 10 m
dbcAMP and measuring progesterone accumulation and
P450scc induction.
From the available evidence, it is now clear that, during
prolonged incubations of stimulated MA-10 cells, many
(mainly pregnane-derived) steroids accumulate, because of
the metabolism of progesterone. In a recent publication on
the inhibitory effect of Mu¨llerian inhibiting substance on the
induction of steroidogenic enzymes in MA-10 cells, it was
shown, for the first time, that the cyp17 gene can be activated
strongly in MA-10 cells after 18 h of stimulation with 50 m
dbcAMP (25). This is in contrast to previous findings that
cyp17 gene and 17-hydroxylase/desmolase activity were
absent in MA-10 cells and could not be induced after expo-
sure to dbcAMP (2). Teixeira et al. (25) also showed that this
induction was completely quenched in the presence of mu¨l-
lerian inhibiting substance. However, the reported shifts in
this gene activity, after 18 h of incubation, were not reflected
in changes in progesterone levels. Because the levels of pro-
gesterone at 24 h and 48 h were low and not different, there
was no indication of active steroid production. Only a small
increase in the very low levels of T was observed after 48 h.
From our study with MA-10 cells and also from incubation
studies in the past with immature rat Leydig cells (20) and
H540 rat tumor Leydig cells (21), it is evident that there are
many possibilities for steroid metabolism. Chronic exposure
to dbcAMP could not only further increase the activity of
17-hydroxylase/desmolase in MA-10 cells, but that of other
enzymes as well. Under these conditions, it seems almost
impossible to relate changes in T levels to changes in cyp17
gene activity.
Since their introduction, MA-10 cells have proven very
useful for studies on hormonal regulation of steroidogenesis.
However, as this paper shows, accurate measurement of
steroidogenesis because of progesterone metabolism is a lim-
iting factor. The described pregnenolone assay gives a better
impression about the real steroidogenic activity than the
progesterone assay; but, for a truly accurate assessment of
steroid synthesis, further improvements in methodology are
necessary. The observed underestimation of progesterone
metabolism may be attributable to the limited capacity of
TLC used in the past to separate steroids. Only 20-dihy-
droprogesterone was identified as a major metabolite (1, 5).
With HPLC, more metabolites could be identified; but even
with HPLC, the major metabolite 5-pregnane-3/-ol-20-
one could not be completely separated from progesterone. It
is therefore possible that this metabolite was also formed in
the MA-10 cells used in the previous studies but could not
be detected with the TLC system. Also, it remains to be
investigated whether sublines of MA-10 cells with different
steroid (progesterone) metabolizing capacities now exist. If
indeed, sublines of MA-10 cells exist, with different activities
of steroid-metabolizing enzymes, this will further complicate
quantitative assessment of steroidogenesis via progesterone
measurements.
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Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century
NIDDK, NIH: April 8–9, 2002
A 1990 NIH Concensus Development Conference on Asymptomatic Primary Hyperparathyroidism, spon-
sored by NIDDK, explored the causes and effects of this disease, developing a consensus on how to treat
it. Together with a research agenda, the consensus statement provided landmarks for basic and clinical
approaches to the disease. Since then, many new advances have occurred, in many instances providing new
approaches to treatment. Now in 2002, this workshop will attempt to define the current state of the art by
focusing on the latest basic and clinical advances that have been made in our understanding of this disease,
with an eye on identifying new directions for the 21st century. Posters are welcome. For further information,
call (301) 493-9674 Ext. 104 or visit the meeting Web site (www.phpt.niddk.nih.gov).
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